(Q51085238)

English

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

scientific article published on 13 May 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Francesco Grossi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Francesco Grossi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Alessandra Bearz

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Claudio Doglioni

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Vanesa Gregorc

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Silvia Novello

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Chiara Lazzari

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sandro Barni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Manlio Mencoboni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Tommaso De Pas

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Filippo de Marinis

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Irene Floriani

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Valter Torri

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Alessandra Bulotta

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Angela Cattaneo

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Julia Grigorieva

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Maxim Tsypin

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Joanna Roder

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Matteo Giaj Levra

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Fausto Petrelli

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Silvia Foti

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Mariagrazia Viganò

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Heinrich Roder

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

13 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

713-721

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of EGFR kinase inhibitors: not always greater than the sum of its parts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized clinical trials with biomarkers: design issues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues in using progression-free survival when evaluating oncology products

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970162-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70162-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24831979%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51085238&oldid=1767109847"